Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2003

View Archived Issues

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Isis Pharmaceuticals

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Proneuron

Improved motor response found with CP-101606 in hemiparkinsonian rats

HP-184 improves hindlimb movement and myelination in rats with spinal cord injury

Subjective improvement in spasticity associated with cannabinoids in multiple sclerosis

Kalypsys and CV Therapeutics collaborate on cardiovascular disease

Boehringer Ingelheim exercises therapeutic antibody option

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Ortec

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Oncolytics Biotech

Prevacid NapraPAC receives FDA approval

Good tolerability profile for OSI-461 in advanced cancer patients

FTY-720 exerts selective antitumor effects on hepatoma cell lines

New immunosuppressants and their therapeutic use reported by Sankyo

Novel TLR modulators with utility in sepsis developed at Mochida

New prostanoid EP4 antagonists under study at Pfizer

Merck presents new GABA(A) ligands for anxiety, convulsions, etc.

New phthalocyanine-based photosensitizers designed by Nihon U. scientists

AstraZeneca presents three related series of alpha7 nAChR agonists

New antifungal azoles prepared and tested at Ranbaxy

Chugai claims new antiestrogens that inhibit osteoclast differentiation

Novel HDAC inhibitors identified at AstraZeneca

Allergan completes Oculex acquisition

BioMS submits Canadian pre-CTA package for MBP-8298

Celltech completes integration of OGS

Phase I/II study evaluates Advexin oral rinse for oral premalignancies

Encouraging preliminary results from rat carcinogenicity study of Preos

Promising preliminary phase I data for HER-2 Protein AutoVac vaccine

SkyePharma seeks U.K. approval of DepoMorphine

Canadian CTA filed for Tectin in refractory severe chronic pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...